-
: Designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (α4β2 nAChR, α7nAChR, α9* nAChR, GIRK1/2, GIRK1/4, etc.) Conducting
-
across all aspects of medicinal chemistry, including: Designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (42 nAChR
-
. They will collaborate closely with cross-functional partners within CQP and across the broader development organization, applying deep domain knowledge and advanced quantitative methods to inform critical
-
, applying deep domain knowledge and advanced quantitative methods to inform critical development decisions. At Northeastern University, the Fellows will engage in scientific publication, conference
-
of medicinal chemistry. The candidate will be responsible for designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (a4b2 nAChR
-
understanding of the other function's responsibilities to enable them to be an optimal collaborator and colleague. During the fellowship, the fellow will work within Regulatory Affairs to gain experience in
-
care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development to prepare fellows for a successful career in the pharmaceutical industry
-
congress and information booths · Contributing to the execution of omnichannel and digital strategy within Medical Affairs to ensure optimal orchestration of scientific information to key stakeholders
-
practical clinical knowledge to enable efficient and effective drug development. Clinical Scientists contribute throughout the development cycle from Phase 1 to IND submission. They are data-driven